Rajesh, R and Pandey, Sureshwar (2009) Safety aspects of anti-asthma treatment. Indian Journal of Hospital Pharmacy, 46. pp. 13-18.

PDF 80_RR.pdf - Published Version Restricted to Registered users only Download (83kB) | Request a copy

Abstract

Asthma is a syndrome characterized by airflow obstruction that varies markedly, both spontaneously and with treatment. Asthmatics harbor a special type of inflammation in the airways that makes them more responsive than nonasthmatics to a wide range of triggers, leading to excessive narrowing with consequent reduced airflow and symptomatic wheezing and dyspnea. Obstruction is often reversible either spontaneously or with treatment. Pharmacological therapy should involve early anti-inflammatory treatment in all but the mildest asthmatics with lowest doses of therapy that provide good symptoms control with minimal or no side effects, and the best drug delivery device is one that the patient can use correctly. This review aims to discuss issues of safety of asthmatics with latest information and serve as an education material for practicing pharmacists.

Item Type:	Article
Subjects:	Pharmacy > MCOPS Manipal > Pharmacy Practice
Depositing User:	KMC Manipal
Date Deposited:	13 Jul 2011 04:07
Last Modified:	13 Jul 2011 04:07
URI:	http://eprints.manipal.edu/id/eprint/537

Actions (login required)

View Item